Johnson & Johnson
NYSE: JNJ
$164.82
-$1.33 (-0.8%)
Closing Price on September 19, 2024
JNJ Articles
24/7 Wall St. has evaluated all pharmaceutical and biotech companies that pay dividend yields above 2% based on their current prices.
Published:
Last Updated:
Johnson & Johnson shares took a hit after earnings, but it was more than just the earnings and guidance to blame. Some rivals may have been winning at the company's expense.
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Wednesday included Apple, Canopy Growth, Cheniere, CSX, Johnson & Johnson, Motorola, Slack, Tilray and VMware.
Published:
Last Updated:
Johnson & Johnson shares traded lower despite beating earnings. It turns out that there are some issues outside of earnings that shareholders are having a hard time quantifying.
Published:
Last Updated:
Johnson & Johnson retreated though it reported better than expected second-quarter before the markets opened on Tuesday.
Published:
Last Updated:
Johnson & Johnson is scheduled to report its most recent quarterly results before the markets open on Tuesday.
Published:
Last Updated:
24/7 Wall St. has put together a preview of Johnson & Johnson, Microsoft, Netflix and the other most prominent of the many earnings reports that are expected this week.
Published:
Last Updated:
24/7 Wall St. screened the top ESG ETFs to see how they differ or are similar. It turns out that these funds have severe overlaps, with Microsoft, Apple, Johnson & Johnson, Alphabet, Procter...
Published:
Last Updated:
After a review of the analyst calls for the week of May 17, 10 stocks stood out. They have either large market caps or are well known to the public, and Wall Street analysts have Buy or Outperform...
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Thursday included Cisco Systems, Deere, Dillard's, Johnson & Johnson, L3 Technologies, Macy's, Occidental Petroleum, SunRun and Valero...
Published:
Last Updated:
Here is a slate of 15 companies that most retirees likely would want to own in their portfolio now, including AT&T, Boeing, Pfizer and Walmart.
Published:
Last Updated:
Johnson & Johnson released better-than-expected first-quarter financial results before the markets opened on Tuesday.
Published:
Last Updated:
Johnson & Johnson is scheduled to release its first-quarter financial results before the markets open on Tuesday, and expectations are muted.
Published:
Last Updated:
During times of uncertainty and fear, many investors have to look for a place to hide when they know that they have to keep having income from investments to supplement their income, retirement or...
Published:
Last Updated:
Johnson & Johnson shares dipped on Thursday on news that a California jury awarded $29 million to a woman that claimed its talcum-powder-based products caused her cancer.
Published:
Last Updated: